SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-21-000034
Filing Date
2021-03-04
Accepted
2021-03-04 16:07:53
Documents
3
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant_8-kx2020xearnings.htm 8-K 22915
2 EX-99.1 opntq4fy2020earningspressr.htm EX-99.1 77176
3 image_01.jpg GRAPHIC 85140
  Complete submission text file 0001385508-21-000034.txt   218841
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 21714208
SIC: 2834 Pharmaceutical Preparations